Yaz Settlement News Provided by the Skikos Law Firm, New Claims Still Accepted

Yaz lawsuits continue to result in settlements for victims of blood clots and related injuries such as stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE). Readers can learn more at http://www.lawsuit-yaz.com/ or call (888) 824-5105 to speak with an experienced Yaz lawyer at no cost.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
These publicly-available figures indicate an average Yaz lawsuit settlement amount of $207,000 per case.

San Francisco, CA (PRWEB) May 08, 2013

The Skikos law firm reported today that settlement agreements have been reached in approximately 5,700 claims involving Yaz, Yasmin, Ocella, and Gianvi. These birth control pills have been the subject of ongoing litigation since 2009. Recent financial reports from Bayer, the defendant in the litigation, indicate the value of Yaz settlements reached to date while negotiations continue.

In its latest newsletter to stockholders (available at http://www.stockholders-newsletter-q1-2013.bayer.com/), Bayer detailed its financial performance for the first quarter of 2013. The report stated that as of April 15, 2013, the company had reached agreements to settle approximately 5,700 claims for a total of $1.18 billion. These publicly-available figures indicate an average Yaz lawsuit settlement amount of $207,000 per case. The Skikos firm represents women nationwide who suffered blood clot injuries while taking Yaz, Yasmin, Ocella, or Gianvi, and the firm's clients are among those referenced in Bayer's settlement figures.

The Skikos firm previously reported on Bayer's public financial statements, such as the company's 2012 Annual Report. These prior reports similarly show an average case value of over $200,000.

The actual Yaz settlement amounts received by Skikos clients and the clients of other firms, however, are treated as confidential and vary on a case-by-case basis. The value of any case depends on the specific side effects experienced by the plaintiff and the particular legal damages she incurred. The firm encourages potential claimants to consult an experienced Yaz lawyer for an informed evaluation of their case.

Bayer's quarterly newsletter further stated that the company would continue to investigate claims and potentially offer settlements to victims of blood clot injuries, such as stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE). Despite the ongoing nature of Yaz settlement discussions, the Skikos firm cautions that certain time limitations can impact the ability to pursue new cases. Accordingly, readers with a potential Yaz, Yasmin, Ocella, or Gianvi lawsuit should consult a qualified attorney in a timely manner to safeguard their legal rights.

The Yaz lawyers at the Skikos firm provide consultations at no cost. Readers can reach the firm at (888) 824-5105 or through http://www.lawsuit-yaz.com/ to learn more.